Hematology at UMC Hospitals

UMC Hospitals, Navi Mumbai provides consultant-led care for benign and malignant blood disorders with coordinated diagnostics, day‑care therapies, inpatient support, and multidisciplinary follow‑up designed for safety, comfort, and timely outcomes.

Why choose UMC

• Dedicated hematologists supported by hematopathology, oncology, transfusion medicine, critical care, and pharmacy.
• Rapid, accurate diagnostics and protocol-driven treatment pathways for both routine and complex conditions.
• Day‑care infusion and transfusion services to minimize hospital stay while maintaining rigorous monitoring and comfort.

Conditions Treated

• Anemias: iron deficiency, B12/folate deficiency, hemolytic anemias, anemia of chronic disease.
• Bleeding and clotting: hemophilia, von Willebrand disease, thrombophilia, DVT/PE, DIC.
• Hemoglobinopathies: thalassemia syndromes, sickle cell disease with structured transfusion and chelation plans as indicated.
• Platelet and immune disorders: ITP, TTP, aplastic and other marrow failure syndromes.
• Hematologic cancers: acute/chronic leukemias, lymphomas, multiple myeloma, MDS, MPN.

Diagnostic Services

• Core hematology: complete blood counts, peripheral smear review, reticulocyte indices, hemolysis panels.
• Coagulation: PT/INR, aPTT, fibrinogen, D‑dimer, factor assays, inhibitor screens as indicated.
• Bone marrow: aspiration/biopsy with expert hematopathology reporting for diagnosis and disease staging.
• Advanced testing: flow cytometry, cytogenetics, FISH, and molecular assays for risk stratification and targeted therapy planning.
• Hemoglobinopathy testing: HPLC and related panels for comprehensive evaluation and counseling.

Treatments and Programs

• Transfusion therapy: packed red cells, platelets, plasma, cryoprecipitate, and factor concentrates with stringent compatibility and monitoring.
• Chemotherapy and targeted therapy: evidence-based regimens for leukemias, lymphomas, myeloma, and other hematologic cancers in day‑care and inpatient settings.
• Anticoagulation clinic: initiation, monitoring, peri‑procedural planning, and reversal strategies.
• Hemophilia and rare bleeding disorders: factor replacement, inhibitor management, bleed-prevention education, and emergency plans.
• Thalassemia and sickle cell programs: transfusion protocols, chelation therapy coordination, vaccination, and infection prevention.
• Coordination for hematopoietic stem cell transplantation via partner centers when clinically indicated.

Day‑care and Inpatient care

• Day‑care: chemotherapy infusions, intrathecal therapy, therapeutic phlebotomy, and transfusions in a monitored setting with infection-control measures.
• Inpatient: induction chemotherapy, neutropenic fever, severe bleeding, thrombotic crises, and complex supportive needs with multidisciplinary oversight.

Safety and Quality

• Transfusion safety: rigorous cross-matching, bedside checks, and post‑transfusion monitoring to limit reactions and alloimmunization.
• Infection prevention: vaccination guidance and protective protocols for immunocompromised patients on chemotherapy or immunosuppression.
• Standardized checklists: bone marrow procedures, intrathecal therapy, anticoagulation management, and central line care.

The Care Journey

• First visit: comprehensive history and examination, targeted labs/imaging, and a written plan with goals, timelines, and precautions.
• Treatment: stepwise therapy balancing efficacy and safety with clear red‑flag guidance and supportive measures.
• Follow‑up: scheduled reviews for counts, coagulation status, disease markers, toxicity monitoring, and dose adjustments.

Preparing for Consultation

• Bring prior reports: CBC/coagulation profiles, iron and hemolysis panels, bone marrow or biopsy reports, and any imaging.
• Medication list: include anticoagulants/antiplatelets, supplements, and any recent antibiotics or chemotherapy.
• History details: bleeding/bruising, prior clots, transfusion reactions, family history, and vaccination status.

FAQs

• What does a hematologist treat? Specialists in blood, bone marrow, and lymphatic disorders—from anemia and clotting problems to leukemias and lymphomas.
• Are transfusions safe? Yes, with strict compatibility testing and monitoring; components are chosen to meet clinical goals while minimizing risk.
• Can therapies be day‑care based? Many infusions, intrathecal treatments, and transfusions are safely delivered without admission in monitored units.
• When is bone marrow testing needed? To confirm diagnoses, stage disease, guide treatment choices, and assess response or relapse.
• Is transplant always required for blood cancers? No; transplant is reserved for specific diseases and risk categories, while many respond to non‑transplant regimens.

Team and Support

Hematologists, hematopathologists, medical oncologists, transfusion specialists, trained nurses, pharmacists, dietitians, physiotherapists, and infection‑control practitioners deliver coordinated, personalized care.

Book an Appointment

For a Hematology consultation, day‑care therapy scheduling, or a second opinion at UMC Hospitals, Navi Mumbai, the care team will help with preparation, timelines, and next steps.